Cargando Eventos

« Todos los Eventos

  • Este evento ha pasado.

Targeting RAS: New Avenues and Challenges

septiembre 13 - septiembre 15

 

RAS oncogenes were considered undruggable for decades. Yet, this situation changed considerably with the development of new drugs targeting different mutant isoforms culminating in the approval of the first RAS-targeting drug in 2021. Nevertheless, a better understanding of the basic principles of RAS signaling may guide the development of improved therapeutic options.

The goal of this symposium is to highlight recent advances in RAS biology and novel therapeutic strategies to foster scientific discussions as to how the field can advance to address future challenges. At the same time, we plan to nurture dialogue between clinicians, preclinical as well as industrial researchers to envision how current research may guide future clinical practice.

We are inviting basic researchers, clinicians, and pharmaceutical scientists to join us in Salamanca, Spain, in September 2023, at the symposium Targeting RAS: new avenues and challenges.

Detalles

Comienza:
septiembre 13
Finaliza:
septiembre 15
Web:
https://targetingras.com/

Local

Fonseca Auditorium
C/ Fonseca, 3
Salamanca, 37002 Spain
+ Google Map